Emerging role for SGLT2 inhibitors in mitigating the risk of hyperkalaemia in heart failure. Verma S, Dhingra NK, Pandey AK, Cosentino F, et al. Eur Heart J 2022 Jun 10. pii: 6604931. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Verma S, Dhingra NK, Pandey AK, Cosentino F, et al. Emerging role for SGLT2 inhibitors in mitigating the risk of hyperkalaemia in heart failure. Eur Heart J 2022 Jun 10. pii: 6604931. doi: 10.1093.
PMID: 35680380